Dipartimento di Medicina Molecolare

Contenuti del sito

Menu di navigazione - Torna all'inizio


Contenuto della pagina - Torna all'inizio


Malcovati Luca

Professore Associato
Sede:
Ematologia
IRCCS Fondazione San Matteo
Viale Golgi 19 - 27100 Pavia
Telefono+39 0382-503062 (studio) / 0382-503595 (Segreteria)
Fax+39 0382-502250
E-mailluca.malcovati@unipv.it
Orari di ricevimentoPrendere appuntamento via mail
Insegnamenti
Insegnamenti:

  • Blood Diseases, Corso di Laurea in Medicina e Chirurgia (Harvey)
  • Malattie del Sangue, Corso di Laurea in Igiene Dentale
  • Neoplasie Mieloidi, Scuola di Specializzazione in Ematologia
  • Malattie del Sangue, Scuola di Specializzazione in Medicina dello Sport.
  • Ematologia, Scuola di Specializzazione in Medicina Interna
CurriculumCV Malcovati
Pubblicazioni
  • Malcovati L, Papaemmanuil E, Bowen DT, Boultwood J, Della Porta MG, et al. Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium and of the Associazione Italiana per la Ricerca sul Cancro Gruppo Italiano Malattie Mieloproliferative. Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood. 2011 Dec 8;118(24):6239-46. doi: 10.1182/blood-2011-09-377275. Epub 2011 Oct 12. PubMed PMID: 21998214; PubMed Central PMCID: PMC3236114.
  • Papaemmanuil E, Cazzola M, Boultwood J, Malcovati L, Vyas P, et al. Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med. 2011 Oct 13;365(15):1384-95. doi: 10.1056/NEJMoa1103283. Epub 2011 Sep 26. PubMed PMID: 21995386; PubMed Central PMCID: PMC3322589.
  • Malcovati L, Della Porta MG, Pietra D, Boveri E, Pellagatti A, et al. Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. Blood. 2009 Oct 22;114(17):3538-45. doi: 10.1182/blood-2009-05-222331. Epub 2009 Aug 19. PubMed PMID: 19692701.
  •  Malcovati L, Germing U, Kuendgen A, Della Porta MG, Pascutto C, et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes. J Clin Oncol. 2007 Aug 10;25(23):3503-10. PubMed PMID: 17687155.
  •  Malcovati L, Porta MG, Pascutto C, Invernizzi R, Boni M, et al. Prognostic factors and life expectancy in myelodysplastic syndromes classified according to WHO criteria: a basis for clinical decision making. J Clin Oncol. 2005 Oct 20;23(30):7594-603. Epub 2005 Sep 26. PubMed PMID: 16186598.
Collaborazioni
  • Molecular Haematology Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
  • Wellcome Trust Sanger Institute, Hinxton, UK
  • International Cancer Genome Consortium - Chronic Myeloid Disorders Working Group
  • International Working Group for the Prognosis of Myelodysplastic Syndromes
  • Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine University, Düsseldorf, Germany
  • Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • European Registry of Myelodysplastic Syndromes
  • Dana-Farber Cancer Institute, Boston, MA, USA
  • European LeukemiaNet